Argus Research analyst John Staszak downgrades Sysco (NYSE:SYY) from Buy to Hold.
TRxADE Health, Inc.’s Board Of Directors Approves 1-For-15 Reverse Stock Split
TRxADE Health, Inc. (NASDAQ:MEDS) (the "Company"), today announced that its board of directors has approved a 1-for-15 reverse stock split of its common stock. The reverse stock split will take effect at 11:59